Not yet reviewed — this article is pending editorial review by Lyrea.

Ethylphenidate

Psychoactive Class

Chemical Class

Ethylphenidate is a synthetic stimulant of the substituted phenidate class and a close structural analog of methylphenidate (Ritalin). It emerged on research chemical markets around 2010–2011, producing traditional stimulant effects with a profile often regarded as more recreational than its parent compound. At lower doses it enhances focus and productivity, while higher doses tend toward euphoria. Notably, ethylphenidate is caustic and can cause severe nasal damage if insufflated.

Dosage & Duration

Dosage

Threshold~10 mg

Light10-20 mg

Moderate20-40 mg

Strong40-80 mg

Heavy80+ mg

Purity and quality can differ considerably between sources. Users report notable variation in effects from batch to batch, which may be influenced by individual tolerance, personal physiological factors, and differences in isomer composition resulting from synthesis methods.

Duration

Onset20-120 minutes

After Effects1-12 hours

Total4-10 hours

Subjective Effects

Effects vary widely by individual, dose, and context.

Physical

The physical effects of ethylphenidate can be broken down into several components which progressively intensify proportional to dosage.

Dehydration Appetite suppressionIncreased heart rate

Cognitive

The cognitive effects of ethylphenidate can be broken down into several components which progressively intensify proportional to dosage. The general head space of ethylphenidate is described by many as one of extreme mental stimulation, increased focus, and powerful euphoria. It contains a large number of typical stimulant cognitive effects. Although negative side effects are usually mild at low to moderate dosages, they become increasingly likely to manifest themselves with higher amounts or extended usage. This particularly holds true during the offset of the experience.

Thought acceleration Analysis enhancement WakefulnessMotivation enhancement

Forked from Subjective Effect Documentation

by Josie KinsSeptember 2015.

Pharmacology

Pharmacodynamics

Ethylphenidate acts as a norepinephrine-dopamine reuptake inhibitor, binding to and partially blocking the transporter proteins that normally clear these monoamines from the synaptic cleft. Compared to methylphenidate, it shows greater selectivity for the dopamine transporter (DAT) with approximately equivalent efficacy, while displaying significantly reduced activity at the norepinephrine transporter (NET). It may also function as an inverse agonist at the dopamine transporter, inducing transporter reversal and subsequent dopamine release in a manner distinct from classical reuptake inhibition. The eudysmic ratio of ethylphenidate is superior to that of methylphenidate. All available pharmacodynamic data have been drawn from rodent studies.

Pharmacokinetics

Ethylphenidate is metabolized into methylphenidate and ritalinic acid. Small amounts of ethylphenidate can also be formed in vivo via hepatic transesterification when ethanol and methylphenidate are coingested, though the quantities produced are not considered pharmacologically significant.

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check

TripSit

Tolerance

Full Tolerance

With sustained repeated ethylphenidate use, many effects may weaken, leading users to need larger doses to obtain similar results.

Baseline Reset

1-2 weeks

Half Tolerance

3-7 days

Cross Tolerance

Dopaminergic stimulants

Harm Potential

Addiction & Dependence

Psychological

Moderate

Ethylphenidate carries a moderate addiction risk and a high potential for abuse, and psychological dependence can develop in some users. Compulsive redosing is commonly reported. Cravings may occur after sudden cessation.

Physical

Withdrawal effects have been reported upon cessation of chronic use, though the specific nature and severity of physical dependence is not well documented due to the substance's limited research history.

Toxicity

Nasal/Mucous Membranes

Ethylphenidate crystals are particularly abrasive and caustic to mucous membranes; repeated insufflation can deteriorate nasal tissue and potentially damage the nasal septum, leading harm reduction sources to recommend against this route of administration.

Respiratory

Inhalation of ethylphenidate irritates lung tissue, resulting in phlegm production and an irritated cough.

Cardiovascular

Prolonged use causes vasoconstriction and cardiovascular strain including increased heart rate and blood pressure; occasional use at moderate doses carries less risk, though chest pain has been reported as a side effect.

Psychosis Risk

Abuse at high dosages for prolonged periods can result in stimulant psychosis presenting with paranoia, hallucinations, or delusions. Based on research into related stimulants, approximately 5–15% of users who develop stimulant psychosis may not fully recover, though antipsychotic medications can effectively resolve acute symptoms.

History & Culture

Ethylphenidate emerged on the recreational drug market around 2010-2011 and gained increasing popularity over the subsequent years. It became primarily distributed as a research chemical through online vendors, exploiting its grey-area legal status in various jurisdictions during this period. The…

Legality

International

The Commission on Narcotic Drugs' 2015 report records Decision 58/5 to include ethylphenidate in Schedule II. The UN Treaty Collection is the current official treaty-status source. This establishes international scheduling, not a verified domestic criminal/medical conduct outcome for any core jurisdiction.

By Country

United StatesIllegalSchedule I

21 CFR 1308.11(f)(6)³³³⁴³⁵

Ethylphenidate is expressly listed as a Schedule I stimulant at 21 CFR 1308.11(f)(6), under the chemical designation ethyl 2-phenyl-2-(piperidin-2-yl)acetate and DEA code 1727. Federal law prohibits knowing or intentional unauthorized possession of a controlled substance, and prohibits manufacture, distribution, dispensing, or possession with intent except as authorized.

AustriaIllegalSuchtgift Anhang IV

Suchtgiftverordnung, Anhang IV.1; Suchtmittelgesetz §§ 5, 27¹²³

Ethylphenidat is expressly named in Annex IV.1 of Austria’s Suchtgiftverordnung, as a substance in Annex II to the UN Convention on Psychotropic Substances under § 2(2) Suchtmittelgesetz. The Suchtmittelgesetz limits acquisition, possession, production, transport, import, export, offer, transfer, and supply to medical, dental, veterinary, or scientific purposes under the Act; unauthorized acquisition, possession, production, transport, import, export, offer, transfer, or supply is criminalized. The current Suchtgift-Grenzmengenverordnung also lists Ethylphenidat with a 10.0 g threshold quantity, corroborating its current controlled-drug treatment.

CanadaIllegalSchedule III item 2(1)

Controlled Drugs and Substances Act, Schedule III item 2; ss. 4-7⁶

Listed on the Controlled Drugs and Substances Act in Schedule III as of May 5, 2017. Previously unscheduled with no analog law covering it.

ColombiaRestrictedLista Verde II

Resolución 116 de 2026⁹¹⁰

Colombia expressly lists ethylphenidate (Etil 2-fenil-2-(piperidin-2-il) acetato) as a substance under special control in Lista Verde, Lista II. Resolución 116 de 2026 modified the technical annexes to Resolución 315 de 2020 and took effect on its issuance, 27 January 2026. The national control framework covers importation, exportation, processing, synthesis, manufacture, distribution, dispensing, purchase, sale, destruction, and use of substances subject to fiscalization; this is a direct substance-specific listing rather than an inference from methylphenidate.

FinlandIllegalNarcotic

Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, liitteet¹¹¹²

Finland’s current Government Decree 543/2008 expressly lists Etyylifenidaatti as a substance deemed a narcotic; the current consolidated decree incorporates the 2025 amendment history. The Narcotics Act (373/2008) prohibits narcotics production, manufacture, import, export, transport, transit, distribution, trade, handling, possession, and use, subject to its limited statutory authorization exceptions.

IndonesiaPrescription onlyPsychotropic Group II

Permenkes 14/2025; UU 5/1997 arts. 4, 14, 36, 62¹⁴¹⁵

Indonesia expressly lists ethylphenidate as ‘ETILFENIDAT’, with the chemical name Etil-2-fenil-2-piperidina-2-ilasetat, in Psikotropika Golongan II. The current classification regulation took effect on 28 November 2025 and repealed Permenkes 6/2025; Group II substances are defined as medicinal substances used in therapy and/or science with a strong dependence potential. Psychotropics may be used only for health care and/or science; patient supply is by prescription, and a user may possess, store, or carry it only for treatment/care with proof of lawful acquisition. Unauthorized possession, storage, or carriage is criminalized by Article 62 of Law 5/1997.

JerseyIllegal

Controlled under the Misuse of Drugs (Jersey) Law 1978.

NorwayUnscheduledCitation needed

Not specifically listed as controlled under the Forskrift om narkotika (narcotics regulation). Despite structural similarity to methylphenidate, Norwegian law does not automatically control ethylphenidate as an analogue.

PolandIllegalII-P psychotropic

Rozporządzenie Ministra Zdrowia z 17 August 2018 r. w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych (tekst jednolity: Dz.U. 2024 poz. 1139), załącznik nr 1, grupa II-P, poz. 15²³²⁴

Ethylphenidate is expressly listed in Poland's group II-P psychotropic-substances schedule, rather than inferred from the separate methylphenidate entry. The official consolidated regulation identifies it as 2-fenylo-2-(piperydyn-2-ylo)octan etylu; the official ELI record for the underlying regulation reports it as in force, and the schedule is issued under the Act on Counteracting Drug Addiction.

SwedenIllegalnarkotika

Förordning (1992:1554) om kontroll av narkotika, bilaga 1; Narkotikastrafflag (1968:64) 1 §²⁷²⁸²⁹

Ethylphenidate is expressly listed as etyl-2-fenyl-2-(piperidin-2-yl)acetat (etylfenidat) under central stimulants in Annex 1 to the Swedish narcotics-control regulation. Annex 1 substances are narcotics under the Narcotics Penal Law; unauthorized transfer, manufacture for abuse, acquisition for transfer, non-personal handling, possession, and use are criminalized, while authorized medical, scientific, specified public-benefit, or permitted industrial handling is governed by the narcotics-control law.

UkraineIllegalTable I List 2

Cabinet of Ministers Resolution No. 770 (6 May 2000), current consolidated text³⁰³¹

Ukraine expressly lists EP (EPH, етилфенідат) with the chemical name ethyl 2-phenyl-2-(piperidin-2-yl)acetate in List No. 2 of Table I. That list is designated for particularly dangerous psychotropic substances whose circulation is prohibited. The national drugs law provides that Table I substances are prohibited from circulation in Ukraine, subject only to the law's limited exceptions for listed substances; no exception specific to ethylphenidate is identified here.

AustraliaControlled (analogue provisions)Citation needed

Australian state and federal legislation contains provisions covering analogues of controlled drugs. Ethylphenidate falls under these provisions as an analogue of methylphenidate.

BrazilIllegalF2 proscribed

Portaria SVS/MS 344/1998, Annex I, List F2 (as updated)⁴⁵

Brazil lists ethylphenidate by name in List F2, the list of psychotropic substances whose use is proscribed in Brazil. The consolidated Annex identifies it as "acetato de etil-2-fenil-2-(piperidin-2-il)", directly matching ethyl phenyl(piperidin-2-yl)acetate rather than relying on methylphenidate or an analogue rule. Portaria 344, art. 4 prohibits production, manufacture, import, export, commerce, and use of proscribed substances, subject to its narrow authorized research and scientific-work exception.

ChinaIllegalnon-medical controlled

2025 Non-medical Narcotic Drugs and Psychotropic Substances Catalogue⁷⁸

Ethylphenidate is expressly listed as catalogue item 110, under the Chinese name 哌乙酯, with the systematic name Ethyl 2-phenyl-2-(piperidin-2-yl)acetate, CAS 57413-43-1, and the synonym Ethylphenidate. The joint 21 July 2025 catalogue notice took effect on publication and replaced the former supplemental non-medical-control catalogue. Under the current State Council regulation, non-medical narcotic and psychotropic substances may be used for approved experimental research but may not be produced, traded, used, stored, or transported.

DenmarkIllegalCitation needed

Controlled substance as of February 1, 2013.

GermanyIllegalBtMG Anlage II

Betäubungsmittelgesetz (BtMG), Anlage II¹³

Controlled under Anlage II of the Betäubungsmittelgesetz (Narcotics Act) as of July 17, 2013. Manufacturing, possession, import, export, purchase, sale, procurement, and dispensing without a license is prohibited.

JapanIllegalnarcotic

Narcotics, Narcotic Raw Materials Plants, Psychotropics and Narcotic and Psychotropic Raw Materials, etc. Designation Order, art. 1(91)¹⁶¹⁷¹⁸

Japan expressly designates ethyl phenyl(piperidin-2-yl)acetate (ethylphenidate) and its salts as a narcotic under Article 1(91) of the current Designation Order. The 2017 MHLW notice records that the substance was moved from designated-drug status to narcotic status effective 25 August 2017; narcotic handling is restricted to the licensed pathways established by the Narcotics and Psychotropics Control Act, rather than ordinary possession, import, manufacture, distribution, or use.

NetherlandsIllegalLijst I (ethylfenidaat)

Opiumwet, lijst I; artikel 2¹⁹

Listed in Lijst I of the Opiumwet (Opium Act) as of April 27, 2018.

PhilippinesIllegalDangerous drug

Dangerous Drugs Board Regulation No. 7, Series of 2018; Comprehensive Dangerous Drugs Act of 2002 (RA 9165)²⁰²¹²²

The Dangerous Drugs Board expressly included ethylphenidate in the Philippine list of dangerous drugs through Board Regulation No. 7, Series of 2018; this is direct substance-specific scheduling, not an inference from methylphenidate or an analogue provision. RA 9165 defines dangerous drugs as those in the statutory schedules and provides penalties, unless authorized by law, for importation, sale and related distribution, manufacture, and possession. The DDB's current official Board Regulations archive continues to list the ethylphenidate inclusion regulation, and no repeal or reclassification of it was identified in that archive.

SingaporeIllegalClass A controlled drug

Misuse of Drugs Act 1973, First Schedule, Class A²⁵²⁶

Ethylphenidate is expressly listed as a Class A controlled drug in Singapore’s Misuse of Drugs Act 1973. Unless authorised by the Act, manufacture, import or export, trafficking, possession, and consumption of a controlled drug are offences; the statute’s classification is direct and does not depend on methylphenidate analogue reasoning.

SwitzerlandControlled (Verzeichnis D)Citation needed

Specifically named as a controlled substance under Verzeichnis D of Swiss drug regulations.

United KingdomIllegalClass B

Misuse of Drugs Act 1971, Schedule 2 Part II; sections 3-5³²

Initially placed under emergency control as a Temporary Class Drug in April 2015 along with other phenidates, restricting sale and manufacture. Subsequently classified as a Class B drug on May 31, 2017, making possession, production, and supply illegal.

References

Citations

Automated synthesis
Information aggregated and synthesized using an autonomous workflow built by Josie Kins.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Ethylphenidate article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.

Not yet reviewed — this article is pending editorial review by Lyrea.

Ethylphenidate

Psychoactive Class

Stimulant

Chemical Class

Phenidate

Dosage & Duration

Dosage

Threshold~10 mg

Light10-20 mg

Moderate20-40 mg

Strong40-80 mg

Heavy80+ mg

Duration

Onset20-120 minutes

After Effects1-12 hours

Total4-10 hours

Subjective Effects

Effects vary widely by individual, dose, and context.

Physical

The physical effects of ethylphenidate can be broken down into several components which progressively intensify proportional to dosage.

Dehydration Appetite suppressionIncreased heart rate

Cognitive

Thought acceleration Analysis enhancement WakefulnessMotivation enhancement

Forked from Subjective Effect Documentation

by Josie KinsSeptember 2015.

Pharmacology

Pharmacodynamics

Pharmacokinetics

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check

TripSit

Tolerance

Full Tolerance

With sustained repeated ethylphenidate use, many effects may weaken, leading users to need larger doses to obtain similar results.

Baseline Reset

1-2 weeks

Half Tolerance

3-7 days

Cross Tolerance

Dopaminergic stimulants

Harm Potential

Addiction & Dependence

Psychological

Moderate

Physical

Toxicity

Nasal/Mucous Membranes

Respiratory

Inhalation of ethylphenidate irritates lung tissue, resulting in phlegm production and an irritated cough.

Cardiovascular

Psychosis Risk

History & Culture

Legality

International

By Country

United StatesIllegalSchedule I

21 CFR 1308.11(f)(6)³³³⁴³⁵

AustriaIllegalSuchtgift Anhang IV

Suchtgiftverordnung, Anhang IV.1; Suchtmittelgesetz §§ 5, 27¹²³

CanadaIllegalSchedule III item 2(1)

Controlled Drugs and Substances Act, Schedule III item 2; ss. 4-7⁶

Listed on the Controlled Drugs and Substances Act in Schedule III as of May 5, 2017. Previously unscheduled with no analog law covering it.

ColombiaRestrictedLista Verde II

Resolución 116 de 2026⁹¹⁰

FinlandIllegalNarcotic

Valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, liitteet¹¹¹²

IndonesiaPrescription onlyPsychotropic Group II

Permenkes 14/2025; UU 5/1997 arts. 4, 14, 36, 62¹⁴¹⁵

JerseyIllegal

Controlled under the Misuse of Drugs (Jersey) Law 1978.

NorwayUnscheduledCitation needed

PolandIllegalII-P psychotropic

SwedenIllegalnarkotika

Förordning (1992:1554) om kontroll av narkotika, bilaga 1; Narkotikastrafflag (1968:64) 1 §²⁷²⁸²⁹

UkraineIllegalTable I List 2

Cabinet of Ministers Resolution No. 770 (6 May 2000), current consolidated text³⁰³¹

AustraliaControlled (analogue provisions)Citation needed

Australian state and federal legislation contains provisions covering analogues of controlled drugs. Ethylphenidate falls under these provisions as an analogue of methylphenidate.

BrazilIllegalF2 proscribed

Portaria SVS/MS 344/1998, Annex I, List F2 (as updated)⁴⁵

ChinaIllegalnon-medical controlled

2025 Non-medical Narcotic Drugs and Psychotropic Substances Catalogue⁷⁸

DenmarkIllegalCitation needed

Controlled substance as of February 1, 2013.

GermanyIllegalBtMG Anlage II

Betäubungsmittelgesetz (BtMG), Anlage II¹³

JapanIllegalnarcotic

Narcotics, Narcotic Raw Materials Plants, Psychotropics and Narcotic and Psychotropic Raw Materials, etc. Designation Order, art. 1(91)¹⁶¹⁷¹⁸

NetherlandsIllegalLijst I (ethylfenidaat)

Opiumwet, lijst I; artikel 2¹⁹

Listed in Lijst I of the Opiumwet (Opium Act) as of April 27, 2018.

PhilippinesIllegalDangerous drug

Dangerous Drugs Board Regulation No. 7, Series of 2018; Comprehensive Dangerous Drugs Act of 2002 (RA 9165)²⁰²¹²²

SingaporeIllegalClass A controlled drug

Misuse of Drugs Act 1973, First Schedule, Class A²⁵²⁶

SwitzerlandControlled (Verzeichnis D)Citation needed

Specifically named as a controlled substance under Verzeichnis D of Swiss drug regulations.

United KingdomIllegalClass B

Misuse of Drugs Act 1971, Schedule 2 Part II; sections 3-5³²

References

Citations

Automated synthesis
Information aggregated and synthesized using an autonomous workflow built by Josie Kins.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Ethylphenidate article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.